|
1
|
Eskenazi B and Warner ML: Epidemiology of
endometriosis. Obstet Gynecol Clin North Am. 24:235–258. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Evans S, Moalem-Taylor G and Tracey DJ:
Pain and endometriosis. Pain. 132(Suppl 1): S22–S25. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
D'Hooghe TM, Debrock S, Hill JA and
Meuleman C: Endometriosis and subfertility: Is the relationship
resolved. Semin Reprod Med. 21:243–254. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Chung SY, Kim SJ, Kim TH, et al: Computed
tomography findings of pathologically confirmed pulmonary
parenchymal endometriosis. J Comput Assist Tomogr. 29:815–818.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Fraser IS: Recognising, understanding and
managing endometriosis. J Reprod Sci. 1:56–64. 2008. View Article : Google Scholar
|
|
6
|
Sampson J: Peritoneal endometriosis due to
the menstrual dissemination of endometrial tissue into the
peritoneal cavity. Am J Obstet Gynecol. 14:422–469. 1927.
|
|
7
|
Halme J, Hammond M, Hulka J, Raj S and
Talbert L: Retrograde menstruation in healthy women and in patients
with endometriosis. Obstet Gynecol. 64:151–154. 1984.PubMed/NCBI
|
|
8
|
Brinton LA, Gridley G, Persson I, Baron J
and Bergqvist A: Cancer risk after a hospital discharge diagnosis
of endometriosis. Am J Obstet Gynecol. 176:572–579. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Swiersz L: Role of endometriosis in cancer
and tumour development. Ann NY Acad Sci. 955:281–292. 2002.
View Article : Google Scholar
|
|
10
|
Martin DC: Cancer and endometriosis: Do we
need to be concerned? Semin Reprod Endocrinol. 15:319–324. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Gwinn ML, Lee NC, Rhodes PH, Layde PM and
Rubin GL: Pregnancy, breast feeding, and oral contraceptives and
the risk of epithelial ovarian cancer. J Clin Epidemiol.
43:559–568. 1991. View Article : Google Scholar
|
|
12
|
Fraser IS and Kovacs GT: The efficacy of
non-contraceptive uses for hormonal contraceptives. Med J Aust.
178:621–623. 2003.PubMed/NCBI
|
|
13
|
Fathalla MF: Incessant ovulation - a
factor in ovarian neoplasia? Lancet. 2:1631971. View Article : Google Scholar
|
|
14
|
Ness RB, Cramer DW, Goodman MT, et al:
Infertility, fertility drugs, and ovarian cancer: A pooled analysis
of case-control studies. Am J Epidemiol. 155:217–224. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Booth M, Beral V and Smith P: Risk factors
for ovarian cancer: A case-control study. Br J Cancer. 60:592–598.
1989. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Risch HA, Marrett LD and Howe GR: Parity,
contraception, infertility, and the risk of epithelial ovarian
cancer. Am J Epidemiol. 140:585–597. 1994.PubMed/NCBI
|
|
17
|
Ryan IP, Tseng JF, Schriock ED, Khorram O,
Landers DV and Taylor RN: Interleukin-8 concentrations are elevated
in peritoneal fluid of women with endometriosis. Fertil Steril.
63:929–932. 1995.PubMed/NCBI
|
|
18
|
Lebovic DI, Mueller MD and Taylor RN:
Immunobiology of endometriosis. Fertil Steril. 75:1–10. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Bersinger NA, von Roten S, Wunder DM, Raio
L, Dreher E and Mueller MD: PAPP-A and osteoprotegerin, together
with interleukin-8 and RANTES, are elevated in the peritoneal fluid
of women with endometriosis. Am J Obstet Gynecol. 195:103–108.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Siristatidis C, Nissotakis C, Chrelias C,
Iacovidou H and Salamalekis E: Immunological factors and their role
in the genesis and the development of endometriosis. J Obstet
Gynaecol Res. 32:162–170. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Bersinger NA, Dechaud H, Mckinnon B and
Mueller MD: Analysis of cytokines in the peritoneal fluid of
endometriosis patients as a function of the menstrual cycle stage
using the Bio-Plex platform. Arch Physiol Biochem. 118:210–218.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Moen MH, Hagen B and Onsrud M: CA-125 in
peritoneal fluid from patients with endometriosis. Hum Reprod.
6:1400–1403. 1991.PubMed/NCBI
|
|
23
|
Koninckx PR, Riitinen L, Seppala M and
Cornillie FJ: CA-125 and placental protein 14 concentrations in
plasma and peritoneal fluid of women with deeply infiltrating
pelvic endometriosis. Fertil Steril. 57:523–530. 1992.PubMed/NCBI
|
|
24
|
Matalliotakis IM, Goumenou AG, Mulayim N,
Karkavitsas N and Koumantakis EE: High concentrations of the
CA-125, CA 19-9 and CA 15-3 in the peritoneal fluid between
patients with and without endometriosis. Arch Gynecol Obstet.
271:40–45. 2005. View Article : Google Scholar
|
|
25
|
Amaral VF, Ferriani RA, Sá MF, Nogueira
AA, Rosa e Silva JC, Rosa e Silva AC and Moura MD: Positive
correlation between serum and peritoneal fluid CA-125 levels in
women with pelvic endometriosis. Sao Paulo Med J. 124:223–227.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Bersinger NA, Sinosich MJ, Baber R, Torode
H and Saunders DM: Development of an endometrial explant model for
the investigation of uterine readiness for implantation in the
human. Implantation in Mammals. Serono Symposia; 91. pp. 301–308.
1993
|
|
27
|
Duffy MJ: Role of tumour markers in
patients with solid cancers. A critical review. Eur J Intern Med.
18:175–184. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Anderson MR, Goff BA, Lowe KA, et al:
Combining a symptoms index with CA125 to improve detection of
ovarian cancer. Cancer. 113:484–489. 2008. View Article : Google Scholar
|
|
29
|
Ataseven H, Oztürk ZA, Arhan M, et al:
Cancer antigen 125 levels in inflammatory bowel diseases. J Clin
Lab Anal. 23:244–248. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Drapkin R, Von Horsten HH, Lin Y, et al:
Human epididymis protein 4 (HE4) is a secreted glycoprotein that is
overexpressed by serous and endometrioid ovarian carcinomas. Cancer
Res. 65:2162–2169. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Hellstrom I, Raycraft J, Hayden M, et al:
The HE4 (WFDC2) protein is a biomarker for ovarian carcinoma.
Cancer Res. 63:3695–3700. 2003.PubMed/NCBI
|
|
32
|
Moore RG, Brown AK, Miller MC, et al: The
use of multiple novel tumor biomarkers for the detection of ovarian
carcinoma in patients with a pelvic mass. Gynecol Oncol.
108:402–408. 2008. View Article : Google Scholar
|
|
33
|
Chang X, Ye X, Dong L, et al: Human
epididymis protein 4 (HE4) as a serum tumor biomarker in patients
with ovarian carcinoma. Int J Gynecol Cancer. 21:852–858. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Escudero JM, Auge JM, Filella X, Torne A,
Pahisa J and Molina R: Comparison of serum human epididymis protein
4 with cancer antigen 125 as a tumor marker in patients with
malignant and nonmalignant diseases. Clin Chem. 57:1534–1544. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Moore RG, Miller MC and Steinhoff MM:
Serum HE4 levels are less frequently elevated than CA125 in women
with benign gynecologic disorders. Am J Obstet Gynecol.
206:351.e1–e8. 2012. View Article : Google Scholar
|
|
36
|
Huhtinen K, Suvitie P, Hiissa J, et al:
Serum HE4 concentration differentiates malignant ovarian tumours
from ovarian endometriotic cysts. Br J Cancer. 100:1315–1319. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Anastasi E, Granato T, Coppa A, et al: HE4
in the differential diagnosis of a pelvic mass: a case report. Int
J Mol Sci. 12:627–632. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Hallamaa M, Suvitie P, Huhtinen K,
Matomäki J, Poutanen M and Perheentupa A: Serum HE4 concentration
is not dependent on menstrual cycle or hormonal treatment among
endometriosis patients and healthy premenopausal women. Gynecol
Oncol. 125:667–672. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
McKinnon BD, Bertschi D, Wanner J,
Bersinger NA and Mueller MD: Hormonal contraceptive use and the
prevalence of endometriotic lesions at different regions within the
peritoneal cavity. Biomed Res Int. 2014:5909502014. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Kupker W, Schultze-Mosgau A and Diedrich
K: Paracrine changes in the peritoneal environment of women with
endometriosis. Hum Reprod Update. 4:719–723. 1998. View Article : Google Scholar
|
|
41
|
Brown J, Pan A and Hart RJ:
Gonadotrophin-releasing hormone analogues for pain associated with
endometriosis. Cochrane Database Syst Rev. CD0084752010.PubMed/NCBI
|
|
42
|
Nirgianakis K, Bersinger NA, McKinnon B,
Kostov P, Imboden S and Mueller MD: Regression of the inflammatory
microenvironment of the peritoneal cavity in women with
endometriosis by GnRHa treatment. Eur J Obstet Gynecol Reprod Biol.
170:550–554. 2013. View Article : Google Scholar : PubMed/NCBI
|
